Navigation Links
Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
Date:3/12/2009

additional investor awareness of Meditor and AMT on the Frankfurt and Berlin Exchanges.

The company's first stop on its investor relations tour will be in Munich this Monday 16 March 2009 at Hotel Le Meridien in the Elysee II Suite.

Disclaimer

This release may contain certain "forward-looking statements" with respect to certain of Indenture Investments Ltd's plans and its current goals and expectations relating to its future financial condition, performance, results, strategy and objectives. Statements containing the words "believes", "intends", "expects", "plans", "seeks" and "anticipates", and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty because they relate to future events and circumstances which are beyond Indenture Investments Ltd's control including among other things, Canadian domestic and global economic and business conditions, market related risks, and the performance of financial markets generally; the policies and actions of regulatory authorities, the impact of competition, inflation, and deflation; the timing, impact and other uncertainties of future acquisitions or combinations within relevant industries; and the impact of changes in capital, solvency or accounting standards, and tax and other legislation and regulations in the jurisdictions in which Indenture Investments Ltd. operates. As a result, Indenture Investments Ltd's actual future financial condition, performance and results may differ materially from the plans, goals, and expectations set forth in Indenture Investments Ltd's forward-looking statements. Indenture Investments Ltd. undertakes no obligation to update the forward-looking statements contained in this section or any other forward-looking statements it may make.


'/>"/>
SOURCE Meditor Pharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
2. MAP Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
3. Valeant Pharmaceuticals to Present at Cowen and Company 29th Annual Health Care Conference
4. ISTA Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
5. Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant
6. Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
8. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
9. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
10. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
11. Merz Aesthetics, a Division of Merz Pharmaceuticals USA, Introduces a Universal Language of Aging for Use in Education, Research and Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Although the bite of ... heal well if left alone, an expert notes. ... an adverse reaction to a brown recluse spider bite, ... Poison Center, particularly since these potentially dangerous bites are ... for us to do nothing. The [bite] has classic ...
(Date:7/29/2014)... NJ (PRWEB) July 29, 2014 ... leading pediatricians have joined our network, CarePoint Health ... and Dr. Sushma Kaki. Hundreds of highly skilled ... a comprehensive network of top doctors and practices ... specialties. This latest acquisition represents CarePoint Health’s commitment ...
(Date:7/29/2014)... Mozes HealthDay Reporter TUESDAY, ... patients with just a single dose of the hormone oxytocin ... Japanese researchers report. Known as the "love hormone," oxytocin ... between lovers, and between mothers and their children. In ... area of the brain that has long been associated with ...
(Date:7/29/2014)... Merrick, NY (PRWEB) July 29, 2014 Summer is ... whether that means enjoying a hike, swimming in a pool or ... it’s time for fleas and ticks. The Puppy Store is here ... during the summer months. , It’s almost impossible to completely keep ... can take to minimize the chances of their pets coming into ...
(Date:7/29/2014)... Bret Busacker , a partner in ... appointed to the Board of Directors for the American ... experienced business attorney with a focus on employee benefits ... wide spectrum of topics regarding equity and incentive compensation, ... His clients include public and private businesses, governmental entities, ...
Breaking Medicine News(10 mins):Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2
... Life-Threatening, Genetic,Disease, WASHINGTON, May 13 Alabama has ... requiring that all newborns be,screened for cystic fibrosis at ... screening program for,cystic fibrosis," said Robert J. Beall, Ph.D., ... 40 states are now screening for the,disease. With every ...
... expression of a key enzyme, vitamin D protects healthy ... lead to cancer, University of Rochester Medical Center researchers ... properties of vitamin D, said Yi-Fen Lee, associate professor ... research. Our findings reflect what we see in those ...
... patient care by recognizing quality and,safety in endoscopy, ... American Society,for Gastrointestinal Endoscopy (ASGE) announces the launch ... endoscopy, in all settings,where it is practiced in ... will recognize endoscopy units that follow the ASGE,guidelines ...
... MILLS, Md., May 13 Medifast, Inc.,(NYSE: ... today,announced that Barry B. Bondroff, CPA has been ... Senior Managing Director with SMART, a,diverse team of ... years of experience providing companies of all sizes ...
... New report provides blueprint to fight the environmental triggers ... homes, schools,playgrounds and neighborhoods are riddled with preventable asthma ... a new report released,today by PolicyLink and The California ... do to make our children,s air safer and healthier., ...
... Inc. (Nasdaq: SNSS ) today announced that Eric ... a corporate update at the upcoming Rodman & Renshaw ... on Monday, May 19,2008 at the Le Meridien Beach ... may access a webcast of the presentation by visiting,the ...
Cached Medicine News:Health News:Alabama Begins Mandatory Screening of Newborns for Cystic Fibrosis 2Health News:Vitamin D protects cells from stress that can lead to cancer 2Health News:ASGE Launches Endoscopy Unit Recognition Program 2Health News:ASGE Launches Endoscopy Unit Recognition Program 3Health News:ASGE Launches Endoscopy Unit Recognition Program 4Health News:Medifast, Inc. Names Barry B. Bondroff, CPA to Board of Directors 2Health News:Why Our Kids Can't Breathe in Our Communities 2Health News:Why Our Kids Can't Breathe in Our Communities 3
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The ... basis of products, methods, applications, end users, and ... growth in the microbial identification market. This favorable ... costs (per test) and the time required for ... continuous technological advancements. Furthermore, genotypic methods have high ...
(Date:7/29/2014)... OAKS, Calif., July 29, 2014 Amgen (NASDAQ: ... the second quarter of 2014. Key results include: ... with 8 percent product sales growth driven by strong ... Kyprolis ® (carfilzomib), Prolia ® (denosumab) and ... 25 percent to $2.37, driven by higher revenues and ...
(Date:7/29/2014)... Scripts Holding Company (Nasdaq: ESRX ) announced ... stockholders of $515.2 million, or $0.67 per diluted share.  ... 4, was $1.23 for the second quarter. 1 ... clients with scale, alignment and innovative solutions to lower costs, ... members," stated George Paz, chairman and chief executive officer. ...
Breaking Medicine Technology:Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7
... The Astellas European Foundation is delighted to announce the winner ... of the University of Geneva, Switzerland Last evening, ... of US$ 300,000 to support work on their project entitled ... liver transplantation for hepatocellular carcinoma , at the Astellas European ...
... 2011 Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: ... will be presenting at two upcoming investor conferences taking place ... Mr. Shortall will present at the Rodman and Renshaw Annual ... On Wednesday, September 14, Mr. Shortall will present ...
Cached Medicine Technology:The Astellas European Foundation Winner of Transplantation Grant 2011 Announced 2Unilife to Participate in Two Investor Conferences 2
... This programmable system automates the denaturation ... procedures, and provides walk-away convenience for ... cost unit accepts a wide range ... use, and reduces hands-on time by ...
... DiffSpin Slide Spinner for technique independent ... wedge smears.,DiffSpin is a compact, quiet, ... the preparation of uniformly distributed cell ... with a start-up supply of slides ...
... systems deliver pulsed light over one smooth ... spikes (which may damage skin) that other ... sends a chilled water supply through the ... which is cooled to as low as ...
... small, quiet, high-speed centrifuge. It employs a ... results in nearly vibration- free operation. Light ... speed and full breaking in a few ... a simple push-on/ pull-off; transforming the centrifuge ...
Medicine Products: